Hands-on help for portfolio companies at the points where they most often stall: regulatory strategy, clinical and validation planning, fundraising readiness for the next round, and fractional senior leadership. Your companies engage us directly; you stay informed.
An independent view on the regulatory pathway, evidence plan, scientific claims and commercial model of a company you are considering, written for an investment committee. Scoped per company, with no conflicts of interest.
Practical workshops for accelerator cohorts and portfolio days, for example: what investors look for in a STEM startup, mapping a regulatory pathway for an AI medical device, and building a fundable seed-round plan.
If a founder needs more specialist help than your team or programme can give, introduce them to us. We will reply within 24 hours, give them an honest view of what they need, and tell them if we are not the right fit. Our fixed-scope Investor Readiness Review and Regulatory Pathway Sprint are designed as a sensible first step for exactly these companies.